Mr. Speaker, I would like to thank my colleague from the other side for his question. We have spent time together on public accounts. When we receive the Auditor General's reports, we as a government and as a Parliament make our best efforts to improve what we may think is best for Canadians when we are going through a process or legislation.
In this particular case, we have now got an incredible bill in front of us, put forward by the member for Oakville. It is not only about his family. We all heard the speech he gave in support of this bill. What this bill would do is relate back to our communities and our families about the significance of making, in this case, some very significant changes for the protection of Canadians.
It would provide the monitoring and the ability to take products that may be harmful to us and get the labelling changed. It would introduce monitoring, so we could actually provide assurance that the medications we are taking are safe.
It is not only for adults. We know, in this particular case, that although the product may have been good for an adult, it had some very serious adverse effects for a young person.
To answer my colleague's question, we are moving ahead and we are moving ahead quickly. We want to get this bill into committee, so that if there are changes and, as the Minister of Health has said, if there are good amendments that make sense in moving this forward for the protection of Canadians, we will make them.
I look forward to the support of this bill as we move forward.